Jcog0405
Web3 set 2013 · Patient population. We included all eligible patients from two clinical trials (JCOG0210 and JCOG0405) that were conducted by the JCOG. These phase II trials … Web29 gen 2024 · 141 Background: Neoadjuvant chemotherapy (NAC) with cisplatin plus S-1 (CS) followed by gastrectomy with D2 plus para-aortic lymph node (PAN) dissection is regarded as a standard treatment in Japan for advanced gastric cancer with bulky lymph node (BN) and/or PAN metastasis based on the results of JCOG0405. In JCOG1002, we …
Jcog0405
Did you know?
Web16 giu 2016 · Background: Gastric cancer with extensive lymph node metastasis is commonly considered unresectable, with a poor prognosis. We previously reported the … Web29 giu 2024 · tion. In JCOG0405(tient accrual: February 20–June )he same eligibility criteria as in JCOG0001 received two or three cycles of cisplatin and S-1 therapy and then …
Web2 set 2024 · For patients with bulky N2 and PAN metastases, the 3-year and 5-year OS rates were 7.4% and 0.0%, respectively, which were lower than those of the JCOG0405 study (20.0% and 20.0%). Conclusion The results of our study suggest that D2 lymphadenectomy alone is suitable for GC patients with only bulky N2 metastasis after … Web1 lug 2024 · In JCOG0405 (patient accrual: February 2005–June 2007), patients satisfying the same eligibility criteria as in JCOG0001 received two or three cycles of cisplatin and …
Gastric cancer is the second most common malignancy in the world, and surgical resection remains a vital part of curative treatment for most patients despite recent advances in chemotherapy1,2. Cure is attained by complete resection of the primary tumour and regional lymph nodes (R0 resection)3. The … Visualizza altro Data handling was performed by the JCOG Data Centre. The study protocol was approved by the Clinical Trial Review Committee of the JCOG and the institutional review board at each participating … Visualizza altro The authors thank other members of JCOG Stomach Cancer Study Group: T. Sano (Cancer Institute Hospital of the Japanese Foundation for Cancer Research, … Visualizza altro Between February 2005 and June 2007, 53 patients entered the study from 19 institutions. Follow-up was performed for 5 years after the … Visualizza altro This multi-institutional phase II trial of neoadjuvant chemotherapy followed by surgery with PAN dissection (JCOG0405) achieved much … Visualizza altro Web9 set 2015 · Since 2000, the Stomach Cancer Study Group (SCSG) of the Japan Clinical Oncology Group (JCOG) has therefore conducted a series of Phase II trials (JCOG0001, …
Web16 giu 2016 · Background: Gastric cancer with extensive lymph node metastasis is commonly considered unresectable, with a poor prognosis. We previously reported the results of the use of cisplatin and S-1 as preoperative chemotherapy for gastric cancer with extensive lymph node metastasis; docetaxel, cisplatin, and S-1 (DCS) have now been … in thy name givers giftWeb2 set 2024 · For patients with bulky N2 and PAN metastases, the 3-year and 5-year OS rates were 7.4% and 0.0%, respectively, which were lower than those of the JCOG0405 study (20.0% and 20.0%). Conclusion: The results of our study suggest that D2 lymphadenectomy alone is suitable for GC patients with only bulky N2 metastasis after … in thy namehttp://www.jcog.jp/document/s_0405.pdf new ketch mastWeb1 feb 2011 · 70 Background: GC with ELM, especially in case of M1(LYM), is regarded unresectable in many countries, while challenge is ongoing in Japan to treat them by intensive chemotherapy followed by super extended surgery. In our previous phase II study (JCOG0001) for the same population, iritotecan plus P (IP) chemotherapy followed by … new ketamine treatment for depressionWebJCOG0210 included patients with linitis plastica and large ulcero-invasive tumors, whereas JCOG0405 comprised those with para-aortic or bulky lymph node metastases. Radiologic evaluations were conducted using RECIST in JCOG0405 and JCGC criteria in JCOG0210, because the latter included many patients without measurable lesions. new keto cooking by michael silversteinWebBackground: Locally advanced gastric cancer with extensive regional and/or para-aortic lymph node (PAN) metastases is typically unresectable and associated with poor outcomes. This study investigated the safety and efficacy of S-1 plus cisplatin followed by extended surgery with PAN dissection for gastric cancer with extensive lymph node metastasis. new ketch rig sailboatsWebThe pathological RR defined as residual tumor corresponding to less than one-third the size of the original tumor was 34.6% in 52 eligible patients, which was slightly higher than in JCOG0405 (28.6%). Among all eligible patients, 5-year overall survival was 54.9% (95% confidence interval 40.3–67.3%) at the date cut-off of May 2024. new keto app